Lindsay Standeven, MD, (Johns Hopkins Reproductive Mental Health Center) shares recent research findings on neuroactive steroids and mood symptoms in patients with Polycystic Ovary Syndrome (PCOS).

Date: Friday, June 21, 2024

Time: 12PM ET / 5PM BST - Find your time zone

This is a Professionals Webinar with information aimed at health care professionals & researchers. To attend, join the IAPMD Professional Community with plans starting at just $10/month.

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. Recent literature supports increased associations between PCOS and co-occurring psychiatric conditions, particularly depression, anxiety, bipolar disorder, and eating disorders. This webinar discusses Dr. Standeven's recent research findings on neuroactive steroids and mood symptoms followed longitudinally in patients with PCOS.

Speaker: Dr. Lindsay Standeven, MD

Linsday Standeven is an Assistant Professor of Psychiatry at Johns Hopkins and the Clinical and Education Director of Johns Hopkins Reproductive Mental Health Center. After completing her residency in Psychiatry, Dr. Standeven completed a two-year fellowship in reproductive psychiatry. She is the director of resident training in women's mental health and serves on the educational board of the National Curriculum on Reproductive Psychiatry (NCRP). Her research focuses on the role of neurosteroid changes in pregnancy and PMADs. She has also received NIH funding to study the role of neurosteroids and the psychiatric symptoms of women with Polycystic Ovary Syndrome.

Live webinar attendance is free to IAPMD Professional Community Members and you will automatically receive an invite. Membership includes two monthly webinars and exclusive networking opportunities for $10US/month. FREE for students! Join the IAPMD Professional Community